Merge PACS vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Merge PACS
by Merative
VS
EchoNext
by Pathway Labs

AI Verdict

Merge PACS is an enterprise-level imaging system designed to streamline radiology and cardiology workflows, offering comprehensive image management and integration with various healthcare systems. EchoNext, on the other hand, is a specialized AI tool focused on analyzing standard ECGs to detect hidden structural heart disease. While both operate in the cardiology AI space, Merge PACS provides a broad infrastructure for imaging, whereas EchoNext offers a targeted diagnostic capability for early heart disease detection.

Choose Merge PACS if…

Choose Merative Merge PACS if your organization is a multi-site health system or large enterprise needing to consolidate imaging data and streamline radiology and cardiology workflows across various departments. This tool is ideal for enhancing diagnostic interpretation through AI integration, customizable worklists, and advanced features like synchronized priors scrolling for mammography, while offering flexible deployment options (on-premise, cloud, hybrid).

View Merge PACS →

Choose EchoNext if…

Choose EchoNext if your primary goal is early detection and screening for hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, using standard ECGs. This AI tool is best suited for broad access across major hospitals to community practices, aiming to identify high-risk patients who may require further diagnostic testing like echocardiograms.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Merge PACS EchoNext
Pricing Contact vendor Starts at $600/month
Deployment On-premise, Cloud, Hybrid Available through the OpenEvidence clinical decision support platform.
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Merge PACS

Merge PACS emphasizes intuitive workflows, customizable worklists, and web-based access for remote reading, all designed to enhance the physician experience and reduce complexity. Recent updates specifically address user feedback for faster and more intuitive diagnostic reading, suggesting a strong focus on usability. EchoNext, while integrated into a clinical decision support platform, doesn't provide as many details on its direct user interface or workflow enhancements.

Clinical Value

EchoNext

EchoNext has demonstrated superior diagnostic accuracy compared to cardiologists in detecting structural heart disease from ECGs, with studies showing it identified 77% of structural heart problems compared to 64% for cardiologists. This suggests a significant clinical impact by enabling earlier detection of critical conditions. Merge PACS offers AI integration and enhanced diagnostic workflows, but specific comparative clinical outcome data against human interpretation or other tools are not provided in the same detail.

Pricing & Value

EchoNext

EchoNext offers transparent tiered pricing starting at $600/month, with clear details on implementation fees and annual discounts. This allows potential customers to understand the cost structure upfront. Merge PACS requires contacting the vendor for pricing details, which can make it more challenging to assess its value proposition without direct engagement.

Enterprise Readiness

Merge PACS

Merge PACS is explicitly designed as an enterprise-level PACS, supporting multi-site health systems with flexible deployment options (on-premise, cloud, hybrid) and extensive integration capabilities with EMR/EHR, RIS, HIS, and VNA systems. EchoNext is available through a clinical decision support platform and targets a broad range of practices, but its enterprise-level deployment and integration features are not as extensively detailed.

Innovation

EchoNext

EchoNext is highlighted as the world's first FDA-cleared AI tool for detecting hidden structural heart disease from standard ECGs, representing a significant breakthrough in early cardiac screening. This novel application of AI to a widely available, inexpensive test demonstrates a high degree of innovation. Merge PACS focuses on integrating third-party AI and enhancing existing imaging workflows, which is valuable but less groundbreaking in terms of core AI functionality.

Support & Docs

Merge PACS

Merative provides a Merge Community Hub, webinars, and direct phone support with global numbers for Merge PACS. They also emphasize customer-driven innovation and feedback. While EchoNext is available through the OpenEvidence platform, specific details on its dedicated support resources and documentation are not as readily available.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Merge PACS EchoNext
Tool Name Merge PACS EchoNext
Company Merative Pathway Labs
Description An enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows, consolidates imaging data, and integrates AI insights across multi-site health systems. It supports multi-modality diagnostic interpretation with flexible deployment options. An FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Specialties Cardiology, Radiology Cardiology, Family Medicine, Hospital Medicine, Internal Medicine
Key Features AI integration and readiness (single worklist access to 3rd party AI applications); Customizable, composite worklist for multiple specialties; Cloud-ready architecture (on-premise, cloud, hybrid deployment options); Enhanced diagnostic workflows (e.g., Synchronized Priors Scrolling for mammography, image fusion); Real-time analytics and dashboards (Merge Dashboards); Enterprise-wide image management and consolidation; Integration with EMR/EHR, RIS, HIS, and VNA systems; Secure web-based access for remote reading AI-powered ECG analysis; Detection of hidden structural heart disease; Identifies heart failure risk; Screens for valve disease; Detects pulmonary hypertension indicators; Utilizes standard 12-lead ECGs; FDA-cleared technology; Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring Merge PACS and EchoNext.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Merge PACS is designed for enterprise-level integration with EMR/EHR, RIS, HIS, and VNA systems, offering a customizable worklist that consolidates imaging data and AI insights across multiple specialties and sites. [3, 11, 13, 14, 19, 27, 30, 32] EchoNext, on the other hand, is available through the OpenEvidence clinical decision support platform, which is used by a large number of U.S. physicians, suggesting its integration focuses on providing AI-powered ECG analysis within an existing decision support framework. [3]
EchoNext demonstrates high accuracy in detecting structural heart disease from ECGs, achieving an AUROC of 85% in internal tests and 78-80% in external validation. It also showed higher accuracy (77%) compared to cardiologists (64%) in a study. [1, 2, 3, 4, 5] Merge PACS, as a PACS solution, focuses on enhancing diagnostic workflows across multiple modalities, including mammography with features like Synchronized Priors Scrolling and image fusion, aiming for efficient and accurate interpretation of various imaging studies. [3, 11, 14, 23, 32]
Merge PACS aims to simplify reading activities with intuitive workflows and a customizable worklist, and past implementations of Merge Cardio PACS noted a small learning curve for cardiologists. [6, 8, 23] EchoNext, as an AI tool for ECG analysis, is designed to be a screening tool that analyzes standard 12-lead ECGs, suggesting its integration into existing ECG review processes would be straightforward for physicians. [3]
Merative offers dedicated service and support for Merge products, including 24/7 support, a community hub, and webinars, maintaining end-to-end relationships with customers. [10, 12] For EchoNext, while specific details on customer support are not provided, its availability through the OpenEvidence platform suggests that support might be facilitated through that existing clinical decision support infrastructure. [3]
Merge PACS includes an audit log, visible from within the Merge PACS Watch application, which monitors and logs system events. [16, 17] Radiology systems generally track every action, such as image access, report edits, and data sharing, in a digital record to simplify error detection and ease the audit process. [15, 25, 31] While specific audit-trail features for EchoNext are not detailed, robust audit controls are a general expectation for HIPAA-compliant healthcare AI tools. [25]
Merge PACS is an enterprise-level PACS designed to consolidate imaging data and integrate AI insights across multi-site health systems, supporting flexible workflow configuration and enterprise-wide image management. [14, 18, 22, 30] EchoNext is designed for broad access, from major hospitals to community practices, and its deployment through the OpenEvidence platform suggests scalability for wider adoption across different clinical settings. [3]
A physician would choose Merge PACS for comprehensive enterprise-level image archiving and communication, especially in multi-site health systems with diverse imaging modalities (radiology, cardiology, mammography) and a need for integrated AI insights and customizable workflows. [3, 8, 14, 18, 23, 24, 30] EchoNext would be chosen by a physician primarily focused on early, non-invasive screening for hidden structural heart disease using standard ECGs, particularly in settings where widespread screening for conditions like heart failure, valve disease, and pulmonary hypertension is desired. [1, 2, 3, 4, 5]

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Merge PACS or EchoNext

Backers

Who funded each tool's parent company.

Merge PACS

AI Tool Finder
AI-powered search. Results may not be comprehensive.